Francine Gregoire
Chief Scientific Officer at Addition Therapeutics
Berkeley, California, United States
Find your path to Francine
178 people in our graph share verified history with Francine — schools, employers, funds. One of them is your warm intro.
Nicole GaudelliunlockedFrancine: together at Beam Therapeutics (2018–2022)
×2Francine: together at Moderna
×4Francine: together at Beam Therapeutics
×2Francine: together at CRISPR
Chief Scientific Officer at Addition Therapeutics
Intro paths
→
In turn, Francine can intro founders to Addition Therapeutics's investors below.
Addition Therapeutics's investors · 4
Co-founders at Addition Therapeutics
KC
Kathleen CollinsDirector
Experience
- Addition TherapeuticsChief Scientific Officercurrent2022 — present
- Beam TherapeuticsSenior Vice President, Head of In vivo Programs2021 — 2022Cambridge, Massachusetts, United States
- Beam TherapeuticsVP Liver Diseases2018 — 2021Cambridge, MA
- CRISPR TherapeuticsVice President, Liver Therapeutics2016 — 2018Cambridge, MA
- Moderna TherapeuticsHead, Cardiovascular Preclinical2013 — 2016Cambridge, MA
- Crown Bioscience, Inc.Senior Director & IIBR Site-Head2012 — 2013Kannapolis
- Crown Bioscience, Inc.Senior Director, Cardiovascular and Metabolic Disease Research2011 — 2013USA
- Lilly Singapore Centre for Drug DiscoveryGroup Leader2009 — 2010
- MetabolexAssociate Director, In Vivo Pharmacology2007 — 2009
- MetabolexSenior Scientist, Biology2004 — 2007
- MetabolexScientist III, Biology2001 — 2004
- Parke Davis/PfizerSenior Scientist1999 — 2001
- UC DavisPostdoctoral Scientist1997 — 1999
- Baxter R&DPrincipal scientist1993 — 1995
- Université catholique de Louvainpostdoc1988 — 1989
Skills & more
In VitroDrug DiscoveryAssay DevelopmentIn VivoPharmacologyBiomarkersMolecular BiologyAnimal ModelsMetabolismPharmaceutical IndustryDrug DevelopmentLifesciences
+12 more
R&DClinical DevelopmentBiomarker DiscoveryTarget IdentificationTranslational MedicineHigh Throughput ScreeningCellGenomicsProtein ChemistryImmunologyCell BiologyBiochemistryLanguages English · French
From Francine's professional profile.
Frequently asked questions
- Who is Francine Gregoire?
- Chief Scientific Officer at Addition Therapeutics
- Where does Francine Gregoire work?
- Francine Gregoire is Chief Scientific Officer at Addition Therapeutics.
- Where did Francine Gregoire go to school?
- Francine Gregoire studied at Université catholique de Louvain (Ph.D, Cell Biology).
Same school
Also attended Université catholique de Louvain120
Iñigo López-HuertaCFO at Ysios CapitalCharles de LiedekerkeInvestor at Inventures Investment PartnersPaul VarassoPrincipal at Axeleo CapitalJérôme WittamerCo-founder and Managing Partner at Expon CapitalYves TrouveroyInvestment Partner at E-Capital Equity ManagementVincent BrichardVenture Partner at EQT Life Sciences
+ 114 more
Shared employers
Also worked at Beam Therapeutics8
Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Courtney WallaceInvestor at Third Rock VenturesJason GehrkeInvestor at Third Rock VenturesMike FengHead of Technology and Data Science at F-Prime Capital PartnersAaron EdwardsFounder at KiraGen BioRyan Murray, PhDFounder at KiraGen Bio
+ 2 more
Also worked at CRISPR Therapeutics16
Briggs MorrisonEntrepreneur Partner at MPM BioImpactJerel DavisManaging Director at Versant VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONKurt von EmsterManaging Partner at AbingworthMaria FardisVenture Partner at Frazier Life SciencesTony HoInvestor at Pivotal Life Sciences
+ 10 more
Also worked at Moderna Therapeutics31
Dave JohnsonCo-founder & CEO of Dash BioNoubar AfeyanInvestor at Flagship PioneeringGisella de la RochaVice President of Legal at MPM BioImpactAxel BouchonVenture Partner at ARCH Venture PartnersJordan SilvaCampus Lead at The MBA FundLee CooperManaging Director at Delos Capital
+ 25 more
